Active substance

Results for the substance opicapone

1 result

About this active substance

Opicapone is a catechol-O-methyltransferase (COMT) inhibitor used for the treatment of Parkinson's disease, particularly in patients experiencing motor fluctuations. It works by prolonging the effect of levodopa, thereby reducing the symptoms of the disease.

The medication is taken orally, usually once daily at bedtime, as directed by a doctor. It is important for patients to follow the prescribed dosage and not discontinue treatment without consulting their doctor.

Patients should be aware of potential side effects, such as dyskinesia, constipation, or dizziness. It is important to inform the doctor of any unusual symptoms.

Common side effects include dyskinesia, constipation, dizziness, and insomnia. In rare cases, severe reactions such as allergic reactions or liver disorders may occur. Patients should be informed of these risks before starting treatment.